Impact Of Inflation Decelerates Under Study - RBI

Pune: Yesterday, Y V ReddyRBI Governor, Y V Reddy stated that the deceleration in inflation that dan

Big Expectations From Reliance Energy - Gujral

Technical Analyst Ashwani GujralTechnical Analyst, Ashwani Gujral is of the view that Reliance Energy can touch Rs 720.

Mr. Gujral said that Tata Power and Reliance Energy are the strongest options. Reliance Energy beyond Rs 580 is poised to go up to Rs 720 and for Tata Power, Rs 620 is a key level that should probably be headed in the direction of Rs 750-760.

“I think some rub off from the capital goods space, those electrical equipment stocks is now rubbing off even to the energy stocks,” He added.

Congress Wins Madurai West Seat By 31,115 votes

CongressMadurai: Congress applicant K.S.K Rajendran won the Madurai West assemblage electorate by a ma

HDFC To Reach Rs 2200 Shortly

Technical AnalystHDFC Bank, Ashwani Gujral is of the opinion that Housing Development Finance Corporation (HDFC) has aim of Rs 2200.

Gujral stated, “I think definitely financial space has a lot of strength, the PSU sector was lagging but now with inflation coming down, I think PSU banks will also catch up.”

One will see Rs 1350 shortly on HDFC Bank as it has made a fresh breakout, and HDFC is now hovering to attain a target of 2200.

C & C Constructions Shoot Up On New Order

C & C constructionsC & C constructions trading up 2.04% to Rs 209.60 after its combined deal secured a Rs 400-crore road pact in north India from the National Highways Authority of India.

The scrip touched a high of Rs 214 and a low of Rs 200.15 during the day. On BSE, 1.75 lakh shares of the scrip were traded. In the last one quarter, the stock had an average daily volume of 81,195 shares on BSE.

Torrent Pharma Top Gainer at BSE

Torrent PharmaTorrent Pharma ascended 6.61% to Rs 257.95 and topped gainers in BSE’s ‘A’ group shares. The other gainers in the list were ABB, LIC Housing Finance, Reliance Energy and GMR Infrastructure.
Freshly, Torrent Pharma Ahmedabad based healthcare company had instigated Rimonabant, which is an anti-obesity molecule, for the first time in India under the trade name Rimoslim. The drug aims many cardio-metabolic risk factors that can lead to obesity, type 2 diabetes or dyslipidaemia.

Pages

News in Focus

Tata Chemicals Share Price Target at Rs 876: Geojit Investments Research

Geojit Research has issued an ACCUMULATE rating on Tata Chemicals Limited with a revised target price of Rs 876 per share.

DCB Bank Share Price Target at Rs 228: Ventura Securities

Ventura Securities Limited has issued a BUY recommendation for DCB Bank Limited, setting a compelling target price of Rs 228 over the next 24 months, implying a robust 33.8% upside from the current

Kajaria Ceramics Share Price Target at Rs 1,252: Motilal Oswal Research

Motilal Oswal Financial Services has reiterated a BUY rating on Kajaria Ceramics with a target price of Rs 1,252, implying upside potential of about 19 percent from the current market price of Rs 1

Bajaj Finance Share Price Target at Rs 1,138: Geojit Financial Services

Geojit Financial Services has reiterated its BUY recommendation for Bajaj Finance Limited, projecting a revised target price of Rs 1,138 from the current market price of Rs 1,015,

Shriram Finance Share Price Target at Rs 1,125: Axis Securities

Axis Securities has issued a BUY recommendation on Shriram Finance Limited, establishing an ambitious target price of Rs 1,125 per share—representing a compelling 25% upside from t

Phoenix Mills Share Price Target at Rs 2,210: ICICI Securities

Phoenix Mills Limited, India's premier retail-led mixed-use development company, has received a BUY call from ICICI Securities with an ambitious target price of Rs 2,210, representing a compelling